Abstract. Tissue engineering represents a promising method for generating chondrogenic grafts for reconstructive surgery. In cultured chondrocytes, the dedifferentiation of cells seems unavoidable for multiplication. Stem cells, however, displaying unlimited self-renewal and the capacity to differentiate towards chondrocytes, might be usable after further characterization. As the interactions between the extracellular matrix and the cellular compartment can alter the cellular behaviour, we investigated the expression of integrins using microarray analysis during chondrogenic differentiation of human mesenchymal stem cells (MSC) in comparison with dedifferentiatiating human chondrocytes (HC) harvested during septoplasty. During chondrogenic differentiation of MSC, the fibronectin-receptor (Integrin ß1·5), fibronectin and the GPIIb/IIIa-receptor were downregulated. The components of the vitronectin-receptor (Integrin ·vß3) and CD47 were constantly expressed and ILK was downregulated. Vitronectin and osteopontin were not expressed by the cells. In HC, Integrin ß1·5 in conjunction with the ligand fibronectin were upregulated during dedifferentiation, Integrin ·vß3 as well as the GBIIb/IIIa-receptor were activated on day 21 but neither vitronectin nor osteopontin were expressed by the cells . The integrins, ß2, ß4, ß6, ß8 and ·2, ·4, ·6, ·7, ·11, were not expressed at any time. ILK, CD47, and ICAP were activated with ongoing dedifferentiation. In conclusion, a candidate for signal-transmission is the fibronectin receptor (integrin ·5ß1) in conjunction with its ligand fibronectin. Other receptors, e.g. for vitronectin and osteopontin (·vß3), or their ligands do not seem to be involved in signal transmission for dedifferentiation. The GPIIb/IIIa-receptor might assist the process of dedifferentiation. Intracellularly, ILK, ICAP1 and CD47 might be involved in the transduction of integrindependent signals.
Introduction
In the last few years, the need for chondrogenic grafts in reconstructive surgery has been accretive. Traditional surgical methods for the reconstruction of tissue defects rely on the transplantation of auto-and allogenous tissues or, accordingly, alloplastic replacement with synthetic medical products. The disadvantages of these techniques are the limited availability and donor site morbidity of auto-or allogenic transplants (1) . The overwhelming shortage of donor cells and tissue is a major problem in reconstructive medicine. This problem could be alleviated through the use of autologous adult stem cells for allogenic transplantation (2, 3) . Stem cells are distinguished from progenitor cells by their capacity for both self-renewal and multilineage differentiation (4) . It is this capacity for self-renewal that makes stem cells particularly useful for reconstructive surgery because, in theory, they could provide an unlimited source of autologous donor material for transplantation (5, 6) .
The fundamental premise of tissue engineering is the regeneration of tissue and restoration of organ function through implanting cells/tissue grown ex vivo or stimulating cells to grow into an implanted matrix (7) . Tissue engineering involves the use of cells coupled with biological or artificial matrices which guide the cells during tissue repair or regeneration (8) . These cells can be driven by specific bioactive molecules, ex vivo gene transfer and other physical factors to form neotissues in vitro for future reimplantation in vivo. Alternatively, cells and special matrices, which can include bioactive molecules such as growth factors, can be combined in vivo to attempt to enhance tissue repair (9) .
The promise of tissue engineering is perhaps most relevant to chondrogenic defects because cartilage has little self-healing potential. Numerous in vitro and in vivo investigations into cartilage engineering have been performed. Cartilage is a (17) . A more recent study demonstrated that the chondrocyte expression of ·1ß1, ·5ß1 and ·vß5 was accompanied by weak expression of integrins ·3ß1 and ·vß3 (16) . The Integrin ·2b (ITGA2B) gene encodes platelet glycoprotein IIb, the alpha subunit of the platelet membrane adhesive protein receptor complex GPIIb/IIIa. The beta subunit, GPIIIa, is encoded by the ITGB3 gene. The GPIIb/IIIa complex belongs to the integrin class of cell adhesion molecule receptors that share a common heterodimeric structure with · and ß subunits. The GPIIb/GPIIIa complex acts as a receptor for fibrinogen, von Willebrand factor and fibronectin (19) . Integrin-mediated signaling has so far been characterized to be involved in a variety of cellular processes, such as differentiation, adhesion and migration. Hannigan et al found that Integrin-linked kinase (ILK) coimmunoprecipitated with ß-1 integrin from cell lysates and that overexpression of ILK disrupted cell architecture and inhibited adhesion to integrin substrates, suggesting that ILK regulates integrin-mediated signal transduction (20) . In addition to ILK, integrin cytoplasmic domain-associated protein 1 (ICAP1) interacts with the cytoplasmic domain of beta-1 integrin (21). CD47 or integrin-associated protein (IAP) is a membrane protein that is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to the extracellular matrix (22) .
In vitro analysis of integrin expression during chondrogenic differentiation of mesenchymal stem cells and chondrocytes upon dedifferentiation in cell culture
As the chondrocyte is responsible for modulating its environment and the chondrocyte phenotype is influenced by the diverse components of the extracellular matrix, the investigation of the molecular basis of distinct changes during developmental processes, especially the process of dedifferentiation for the generation of transplants, might broaden the understanding of impediments in the field of tissue engineering. Investigations of gene-expression patterns of human chondrocytes or mesenchymal stem cells (MSC) during chondrogenic differentiation so far have not been performed. The aim of our study was the analysis of gene-expression patterns of MSC compared to dedifferentiating primary chondrocytes harvested during septoplasty in cell-culture.
Materials and methods
Cell culture. Human septal cartilage from 32 patients was harvested during septoplasty. The patients gave informed consent and the Faculty of Medicine Mannheim, University of Heidelberg, Germany, approved the study. Cells were isolated using collagenase and pronase. Cell cultures were carried out in Falcon petri dishes at 37˚C in a 5% CO 2 
Collection and isolation of MSC from bone marrow (BM).
Bone marrow was obtained from the femoral shaft of patients undergoing total hip replacement at the orthopedic department of the University Hospital Mannheim. Cells were aspirated into a 5-ml syringe containing CPD anticoagulant. In total, six specimens from female patients were obtained, with the donor age ranging from 68 to 84 years.
To isolate mononuclear cells (MNCs), the bone marrow aspirates were diluted 1:5 with PBS/2 mM EDTA (Nexell, Baxter, Unterschleissheim, Germany; and Merck, Darmstadt, Germany) and carefully loaded onto Ficoll-Hypaque solution (Amersham, Freiburg, Germany). After density gradient centrifugation at 435 x g for 30 min at room temperature, MNCs were removed from the interphase and washed two to three times with PBS/EDTA. Cell counts were performed using an automated cell analyzer (Cell-Dyn 3200, Abbott, Wiesbaden, Germany).
BM derived MNCs were set in culture at a density of 1x10 5 /cm 2 in 75-cm 2 tissue culture flasks (Nunc, Wiesbaden, Germany, www.nunc.de) in MSCGM medium (MSCGM BulletKit™, Cambrex, St. Katharinen, Germany).
After overnight incubation at 37˚C in a humidified atmosphere containing 5% CO 2 , non-adherent cells were removed and fresh medium was added to the flasks. Cultures were maintained and remaining non-adherent cells were removed by complete exchange of culture medium every three to four days. The flasks were screened continuously to obtain developing colonies of adherent cells. Fibroblastoid cells were recovered between days 7 and 10 after initial plating by using 0.04% Trypsin/0.03% EDTA (PromoCell, Heidelberg, Germany). Recovered cells were replated at a density of 4000-5000 cells/cm 2 as passage 1 (P1) cells and thereafter.
Chondrogenic differentiation. To promote chondrogenic differentiation, 2.5x10 5 cells were gently centrifuged (150 x g, 5 min) in a 15-ml polypropylene tube (Greiner) to form a pellet according to the protocol of Mackay et al (23) . Without disturbing the pellet, the cells were cultured for four weeks in complete chondrogenic differentiation medium (Cambrex) including 10 ng/ml TGFß3 (Strathmann Biotec AG, Hamburg, Germany) by feeding twice a week. After the culture period, cryosections were analyzed by Safranin O staining. The sections were fixed with ice-cold acetone (Sigma) and stained with 0.1% aqueous Safranin O solution (Sigma). Cell nuclei were counterstained with Weigert's iron hematoxylin (Sigma).
For the RNA analysis we harvested and lysed the aggregates in RLT buffer (Qiagen). The lysis was aggravated by freezing the pellet repeatedly in liquid nitrogen.
RNA extraction and microarray hybridization. Extraction of RNA was performed using RNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol and as published previously (24) . The RNA concentration was estimated from the absorbance at 260 nm.
Approximately 1 μg total RNA was used in each microarray experiment and, for amplification and labeling of mRNA, the SMART technique (SMART fluorescent probe amplification kit; BD Clontech, Heidelberg, Germany) was applied according to the manufacturer's protocol. RNA samples from day 1 were labeled with Cy3 and day 6 or day 21 samples were labeled with Cy5 (Cy™3-and Cy™5-monoreactive dye; Amersham Pharmacia Biotech, Freiburg, Germany). Corresponding Cy3-and Cy5-labeled samples were mixed, vacuum-dried and resuspended in 25 μl microarray hybridization buffer (MWG-Biotech; Ebersberg, Germany). Prior to hybridization, the samples were heat-denatured at 95˚C for 5 min. The human 10K (MWG-Biotech) oligo microarray systems on glass slides were used for mRNA profiling. Hybridization of Cy3/Cy5-cDNA was performed using cover slips and a hybridization chamber for 16 h at 42˚C in a water bath. After stringent washing of the glass slides according to the manufacturer's specifications, the hybridization signals of the Cy3 and Cy5 dyes were measured using a microarray laser scanner (GMS418; Affymetrix, MWG-Biotech).
Microarray data analysis and statistics. ArrayVision (Imaging Research, Inc., St. Catharines, ON, Canada) software was used for evaluation and calculation of signal intensities from the raw data images in 16-bit tagged-image-file (TIF) format as described previously. In brief, for evaluation of the hybridization results, we defined a negative (<3.000), a grey area (3.000-4.999) and a positive range (≥5.000) of hybridization signal intensities. Signal-to-background (S:B) values were calculated by dividing the signal intensity for each spot with the background signal intensities of the hybridized glass slide. Computer-assisted evaluation of the raw data provided the mean signal intensity and the signal:background ratio for each individual gene spot. For statistical evaluation, the mean signal intensity and standard deviation (SD) was calculated for each spot from the values obtained in the 10 individual experiments. Functional grouping of genes was performed on the basis of the database supplied by the array manufacturer.
Results

Mesenchymal stem cells Microarray gene expression analysis
Integrins. The expression level and the change in expression of 9832 individual human genes in bone marrow-derived MSC was estimated on the basis of the hybridization signal intensity of each gene-specific probe represented by the microarray system. In the first series of microarray investigation, the gene expression in undifferentiated MSC was compared to the gene expression after chondrogenic differentiation in three paired experiments.
The MSC in their undifferentiated state expressed the components of the fibronectin-receptor (ß1·5) and downregulated these genes during chondrogenic differentiation (ratio Undiff:Diff, 0.58 for ß1 and 0.93 for ·5; Fig. 1 , Table I ). Fibronectin was constantly expressed by MSC and during chondrogenic differentiation (ratio Undiff:Diff, 0.99). The components of the GPIIb/IIIa-receptor were expressed by MSC, ·2b was expressed constantly during chondrogenic differentiation, ·3 was downregulated (ratio Undiff:Diff, 1.55 for ·2b and 0.63 for ·3). Integrin ß3 was not expressed by MSC and, during chondrogenic differentiation (ratio Undiff:Diff, 0.49), Integrin ·v was constantly expressed (ratio Undiff:Diff, 1.49). Integrin ß5 was downregulated during chondrogenic differentiation (ratio Undiff:Diff, 0.68) and Integrin ·10 was not expressed.
Integrin-associated proteins. ILK was inactivated during chondrogenic differentiation (ratio Undiff:Diff, 0.63), CD47 was constantly expressed (ratio Undiff:Diff, 1.02) and ICAP-1a was not expressed.
Chondrocytes
Microarray gene expression analysis. The expression level and the change in expression of 9832 individual human genes in chondrocytes isolated from the septal cartilage was estimated on the basis of the hybridization signal intensity of each genespecific probe represented by the microarray system. In the first series of microarray investigation, the gene expression in primary chrondrocytes (day 1) was compared to the gene expression after 5 and 20 days of cell culture (days 6 and 21, respectively) in five paired experiments.
Integrins. The genes for the components of the fibronectin receptor (integrin ß1·5) were activated during dedifferentiation (Table II ; ß1 day 6:day 1 ratio, 2.73; ß1 day 21:day 1 ratio, 3.47; ·5 day 6:day 1 ratio, 2.11; ·5 day 21:day 1 ratio, 0.74). Fibronectin was constantly expressed during dedifferentiation Table I . Signal intensities of hybridization signals as measured by the microarray laser scanner and calculated by ArrayVision software during chondrogenic differentiation of MSC.
-------------------------------------------------
Signal intensity (mean ± SD) Factor of regulation Undiff Diff Undiff vs. Diff  ----------------------------------------------- 
Bold indicates significant up-(≥2.00) or downregulation (≤0.50).
(day 6:day 1 ratio, 0.87; day 21:day 1 ratio, 1.3). The gene for integrin ·2b was expressed on days 1, 6 and 21 (day 6:day 1 ratio, 0.92; day 21:day 1 ratio, 1.49). The gene for integrin ·v was activated on days 1 and 21 but inactivated on day 6 (day 6:day 1 ratio, 0.28; day 21:day 1 ratio, 0.74). The integrin ·3-gene was activated on days 1 and 6 and then downregulated on day 21 (day 6:day 1 ratio, 1.04; day 21:day 1 ratio, 0.24). The gene for integrin ß3 was expressed in the grey area with a day 6:day 1 ratio of 0.95 and a day 21:day 1 ratio of 0.78. The gene of integrin ß5 was expressed on days 1 and 6 (day 6:day 1 ratio, 1.07) and was then activated on day 21 (day 21:day 1 ratio, 1.84). The genes for integrins ß2, ß4, ß6, ß7 and ß8 were never expressed. Integrin ·10 was expressed on day 1 but then inactivated on days 6 and 21 (day 6:day 1 ratio, 0.35; day 21:day 1 ratio, 0.44) The genes for vitronectin and osteopontin were never expressed. Integrin-associated proteins. The fibronectin-gene was expressed on day 1 and then upregulated on days 6 and 21 (day 6:day 1 ratio, 1.83; day 21:day 1 ratio, 4.06). The gene for ILK was expressed on days 1, 6 and 21 with ratios of 1.32 and 1.06 respectively. Integrin ·e, CD47 and integrin cytoplasmic domain-associated protein 1 (ICAP-1) were not expressed on day 1 but were activated on days 6 and 21 (day 6:day 1 ratios, 1.03, 1.09 and 1.02; day 21:day 1 ratios, 2.5, 2.32 and 1.97).
Discussion
Tissue engineering of cartilage comprises the creation of tissue grafts with autologous chondrocytes, an artificial extracellular matrix and biodegradable polymers. In past years, there have been several investigations with promising results which performed in vitro and in vivo maturation of tissue-engineering transplants for auricular (25) and nasal (26) cartilage. An important task of artificial breeding of tissue is to extract sufficient amounts of cells and to minimize donor site morbidity. So, one important task of tissue engineering is the efficient extraction of vital chondrocytes and adequate expansion (27) . During monolayer culture, the chondrocytes dedifferentiate and lose their chondrocytic phenotype which is reflected on the molecular level by a repression of cartilagespecific collagen type 2 and an induction of type 1 collagen, typical for fibroblastoid cells (28) . So far, no investigation of gene-expression patterns of chondrocytes has been performed. In the present study, characteristic changes of the expression of integrins and integrin-associated proteins were analyzed during dedifferentiation of primary chondrocytes in comparison with the expression during chondrogenic differentiation of mesenchymal stem cells.
The physiological response of chondrocytes to maintenance of the matrix and response to stimuli probably involves signaling from multiple sources including soluble cytokines, mechanical stimulation and signaling from the extracellular matrix. Cell-matrix interactions are important regulators of cellular functions, including matrix synthesis, proliferation and differentiation. This is well exemplified by the characteristically labile phenotype of chondrocytes that is lost in monolayer culture but is stabilized in suspension under appropriate conditions.
During dedifferentiation of the chondrocytes, the components of the fibronectin receptor, integrin ß1·5, were activated. In contrast to these findings, the integrins ß1·5 were downregulated during chondrogenic differentiation of MSC.
It has been previously described that, in primary chondrocytes, the most abundant integrin is the fibronectin-receptor, ·5ß1 (29) , which can also bind collagen 2, and that chondrocytes activate collagen type 2 during dedifferentiation. The upregulation of integrins ß1·5 seems to correlate with these results, as upregulation would facilitate adhesion to collagen 2. Integrins ß1 and ·5 could be markers for synthetic activity as the chondrocytes try to generate an extracellular matrix suitable for their survival. Along with this activation of the fibronectin receptor, an upregulation of fibronectin in the course of dedifferentiation could be observed. Concordant with these results, the analysis of the gene expression of MSC during chondrogenic differentiation revealed a downregulation of integrins ß1·5. So, on the one hand, the fibronectin receptor might be a marker for more undifferentiated, fibroblastoid cells (dedifferentiating chondrocytes, undifferentiated MSC) and, on the other hand, this receptor might assist the process of dedifferentiation.
Other receptors have been described for vitronectin and osteopontin (·Vß3) or laminin (·6ß1) (30, 31) . We found expression of integrin ·v on day 1, downregulation on day 6 and upregulation on day 21. The gene for integrin ß3 was Table II . Signal intensities of hybridization signals as measured by the microarray laser scanner and calculated by ArrayVision software during dedifferentiation of HC. 
-
expressed in the grey area and the gene for integrin ß5 was upregulated on day 21. During chondrogenic differentiation of MSC, the behavior was vice versa: Integrins ß3 and ß5 were downregulated and integrin ·v was inactivated. Integrin ß5 might play a role in vitronectin binding, as McLean and coworkers isolated cDNA clones coding for the ß-5 subunit of the novel integrin receptor involved in cell adhesion to the matrix protein, vitronectin, which had been found in a human lung epithelial-derived cell line. This receptor had an · subunit that appeared to be identical to that in another vitronectin receptor, but the ß subunit was distinctive (32) . In the present study, neither vitronectin nor osteopontin expression was observed, so these proteins do not seem to be involved in the dedifferentiation process.
In human chondrocytes, Camper and coworkers identified an additional type II collagen-binding integrin composed of ß-1 and a 160-kD protein that they designated ·-10. We found downregulation of this integrin on days 6 and 21 and MSC downregulated both, integrins ß1 and ·10, during chondrogenic differentiation. Therefore, the chondrocytes may switch mainly to integrin ·5ß1 with ongoing dedifferentiation (33) .
The strong expression of Integrin ·2b during dedifferentiation of HC was unexpected. Interestingly, there was upregulation of the ·2b-gene during chondrogenic differentiation of MSC and inactivation of the ·3-gene. The Integrin ·2b (ITGA2B) gene encodes platelet glycoprotein IIb, the · subunit of the platelet membrane adhesive protein receptor complex GPIIb/IIIa. The ß subunit, GPIIIa, is encoded by the Integrin ß3 gene. The GPIIb/IIIa complex belongs to the integrin class of cell adhesion molecule receptors that share a common heterodimeric structure with · and ß subunits. The GPIIb/GPIIIa complex mediates platelet aggregation by acting as a receptor for fibrinogen. The complex also acts as a receptor for fibronectin (19) . Integrin ·2b expression seems to be more important in chondrocyte dedifferentiation as the ß3 subunit. Possibly there is involvement of another ß subunit in the assembly of the receptor.
Integrin ·3 showed strong expression on days 1 and 6, but downregulation on day 21 with ongoing dedifferentiation of the cells. It has been shown previously that neuronal migration and layer formation might be regulated through modulation of ·-3-ß-1 integrin-mediated neuronal adhesion and migration (34) . Our experiments suggest that integrin ·3-dependent signaling is abundant in differentiated chondrocytes but is unnecessary in dedifferentiated chondrocytes.
Certain candidate genes from the integrin family might be involved in transducing the signals mediating the dedifferentiation of the chondrocytes in monolayer cell-culture. We aimed to find candidate genes that might transduce the signal to an intracellular level.
One of these candidates was Integrin-linked kinase (ILK). Microarray analysis revealed that the gene for ILK was expressed on days 1, 6 and 21 during the dedifferentiation of HC and the gene was inactivated during the chondrogenic differentiation of MSC. Hannigan et al isolated a gene that interacts with the cytoplasmic domain of ß-1 integrin. They found that ILK coimmunoprecipitated with ß-1 integrin from cell lysates and that overexpression of ILK disrupted the cell architecture and inhibited adhesion to integrin substrates while inducing anchorage-independent growth in epithelial cells, suggesting that ILK regulates integrin-mediated signal transduction (20) . The expression of this gene suggests that integrin-mediated signalling is involved in the process of dedifferentiation.
In concordance with ILK, ICAP1 and CD47 were upregulated (21, 22) during the dedifferentiation of HC and downregulated during the chondrogenic differentiation of MSC. These three proteins involved in integrin-mediated processes during cell adhesion, differentiation and migration were upregulated during ongoing dedifferentiation in concordance with upregulation of the key members of the integrin familiy, e.g. integrin ß1. This substantiates the thesis of integrin-mediated signalling being involved in the process of dedifferentiation.
In conclusion, in the present study, we analysed expression patterns of integrins and related ECM-proteins. One of the candidates for signal-transmission is the fibronectin-receptor (integrin ·5ß1) in conjunction with its ligand fibronectin. Other receptors, e.g. for vitronectin and osteopontin (·Vß3) or laminin (·6ß1) or their ligands do not seem to be involved in signal transmission for dedifferentiation. The strong expression of the components of the GPIIb/IIIa-receptor was unexpected, the latter seeming to be involved in the process of dedifferentiation. Intracellularly, ILK, ICAP1 and CD47 might be involved in the transduction of integrin-dependent signals.
